Mulya.ai
Ticker
CAH
Scenario
Key Inputs
Revenue est.?Analyst
OP margin est.?hist_ind
Reinvestment est.?projected
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?6.5%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?0.526
Beta (levered) ?0.591
Terminal OM% ?0.9%
Segment conc. ?92% dominant
Terminal growth ?4.1%
Bond rating ?AA · 0.90%
ROIC option ?Opt 4 · 23.6%
Prob of failure ?0.0%
Pipeline validated · 2026-07-21

CAH · Cardinal Health, Inc.

$237.922026-07-21
Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors

Intrinsic Value Range Comparison · Mulya.ai

Bull
$220
-7.5% vs market
Base · active
$174
-26.9% vs market
Bear
$125
-47.3% vs market
Mulya.ai vs Analyst IV Comparison?
Bear $125
Base $174
Bull $220
Market $238
Median $256
Market Price $238
Mulya.ai Base $174
Analysts Median $256
Mulya.ai IV range ($125 · $220)
Analysts Range ($235 · $275)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2024.Q3$205.0B0.4%40.5%$447MM−$866MM−$419MM6.3%0.0%−$1.1B$1.40
2025.Q2$226.8B10.7%0.5%26.6%$912MM−$4.2B−$3.3B7.4%0.0%$805MM$3.61
2025.Q3$226.8B0.0%0.5%26.2%$918MM−$3.0B−$2.1B6.7%83.0%$1.4B$3.61
2026.Q2$222.6B-1.9%1.0%26.4%$1.7B−$3.0B−$1.3B6.9%67.6%$3.5B$6.61
2026.Q3$250.5B12.6%0.9%22.8%$1.8B−$1.6B$213MM6.5%62.7%$2.1B$6.6124.3
italics below = DCF projection · 10yr Rev CAGR: 5.8%
2027.Q3$274.0B+9.4%0.9%22.5%$2.0B−$948MM$1.0B6.7%$948MM74.8%$3.1B$8.3128.6
2028.Q3$296.0B+8.0%0.9%22.2%$2.1B−$554MM$1.6B6.9%$1.4B63.2%$3.6B$9.0426.3
2029.Q3$319.3B+7.9%0.9%21.9%$2.3B−$428MM$1.9B7.1%$1.5B60.0%$4.1B$9.8224.2
2030.Q3$336.7B+5.5%0.9%21.6%$2.5B−$251MM$2.2B7.3%$1.7B58.6%$4.3B$10.4322.8
2031.Q3$353.7B+5.1%0.9%21.4%$2.6B−$202MM$2.4B7.5%$1.7B59.0%$4.5B$11.0821.5
Term. Yr+$458.5B4.1%0.9%20.0%$3.4B−$599MM$2.8B8.6%$30.6B23.6%
Active scenario IV: $174 (-26.9% vs market)